VN2R9P

Across TCGA pan-cancer cohorts, VN2R9P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated VN2R9P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher VN2R9P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated VN2R9P expression acts as an unfavorable survival marker, although some lineages such as KIRC and HNSC show a favorable association.

LIHC, BRCA, and KIRC are the cancer types where VN2R9P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.275	0.696	<.001	90	view →
BRCA	OS	Tertile	II,III,IV	0.882	0.960	.002	54	view →
KIRC	DFS	Quartile	All	0.912	0.840	.005	42	view →
CHOL	DFS	Tertile	All	0.098	0.599	<.001	36	view →
UVM	OS	Tertile	All	0.292	0.674	.035	18	view →
GBM	OS	Tertile	All	0.079	0.415	.003	18	view →
MESO	DFS	Tertile	All	0.223	0.412	.023	18	view →
READ	DFS	Tertile	IV	0.027	0.636	<.001	18	view →
LUAD	OS	Tertile	IV	0.325	0.724	.029	18	view →
KICH	OS	Tertile	All	0.831	0.992	.014	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
HNSC	OS	Tertile	IV	0.529	0.353	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

VN2R9P–LIHC (OS)

Open the LIHC breakdown →